Valuation: Monogram Technologies Inc.

Market Cap 244M 213M 196M 183M 346M 23.25B 352M 2.36B 914M 11.33B 915M 895M 39.3B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 200M 184M 171M 324M 21.79B 330M 2.21B 856M 10.62B 858M 839M 36.83B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 2.87
Extreme 2.87
6.42
3 years 1.53
Extreme 1.53
6.55
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
25-10-06Issuer sale

Founder

5,007,622 12.3242%
25-10-06Issuer sale

Director

40,000 0.0984%
25-10-06Issuer sale

Chief Technology Officer

1,312,926 3.2312%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+109.79%+50.75% 244M
+4.20%+4.10%-17.69%+7.03% 120B
+2.92%-2.26%+0.67%-11.16% 12.33B
+7.83%+7.68%+44.69%+108.31% 8.08B
-0.64%+1.67%-48.31%-71.81% 4B
+1.85%+2.81%+18.98%+40.15% 2.57B
-1.23%+3.87%-12.07%-14.48% 1.86B
-0.41%+1.29%-5.26%-25.04% 1.62B
-3.31%-6.90%+221.83%+153.84% 1.58B
Average +1.05%+3.55%+34.74%+26.40% 16.94B
Weighted average by Cap. +3.92%+0.21%-10.20%+10.40%

Financials

2023 2024
Net sales 0.36 0.32 0.29 0.27 0.52 34.81 0.53 3.53 1.37 16.96 1.37 1.34 58.83 -
Net income -13.75M -12.03M -11.05M -10.3M -19.5M -1.31B -19.87M -133M -51.51M -639M -51.59M -50.48M -2.22B -16.33M -14.29M -13.12M -12.23M -23.16M -1.56B -23.6M -158M -61.19M -759M -61.29M -59.97M -2.63B
Net Debt -13.1M -11.46M -10.53M -9.81M -18.58M -1.25B -18.93M -127M -49.08M -609M -49.16M -48.1M -2.11B -15.33M -13.41M -12.32M -11.48M -21.74M -1.46B -22.15M -148M -57.43M -712M -57.52M -56.29M -2.47B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
27
  1. Stock Market
  2. Stocks
  3. MGRM Stock